• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 30, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Dietary Changes Emerge as Potential Therapeutic Strategy for Brain Cancer

Bioengineer by Bioengineer
September 4, 2025
in Cancer
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

blank

Glioblastoma, the most aggressive and lethal form of malignant brain tumor, remains a formidable challenge in oncology. Despite advances in surgery, radiation, and chemotherapy, most patients diagnosed with glioblastoma survive only one to two years post-diagnosis. The relentless nature of this cancer stems from its highly invasive behavior and remarkable ability to evade conventional therapies, underscoring the urgent need for novel treatment strategies grounded in a deeper understanding of its biology.

At the heart of recent breakthroughs is a nuanced exploration of the tumor’s metabolism, particularly how glioblastomas process glucose, a primary fuel source for cells. Unlike healthy brain cells that metabolize glucose primarily to generate the energy and neurotransmitters needed for normal brain function, glioblastoma cells rewire their glucose utilization to fuel rapid growth and tissue invasion. This metabolic reprogramming diverts glucose away from traditional energy pathways toward the production of nucleotides and other macromolecules essential for DNA replication and cellular proliferation.

These insights emerged from a collaborative study by researchers at the University of Michigan, integrating expertise from the Rogel Cancer Center, the Department of Neurosurgery, and the Department of Biomedical Engineering. The team employed sophisticated labeling techniques, injecting isotopically marked glucose into both mouse models and human patients with brain tumors. This approach allowed them to trace glucose’s metabolic fate within living organisms, revealing distinct usage patterns between normal and cancerous brain tissues.

Healthy neurons take up glucose and channel it through glycolysis and the tricarboxylic acid cycle to produce ATP, the energy currency necessary for neuronal activity, and to support the synthesis of neurotransmitters. In stark contrast, glioblastoma cells suppress these pathways and instead reroute glucose towards the one-carbon metabolism pathway and nucleotide biosynthesis. This shift supports the nucleic acid synthesis required for the aggressive proliferation characteristic of these tumors. The finding illustrates a “metabolic fork in the road,” a critical juncture where glucose utilization diverges, dictating cell fate and function.

An additional layer of complexity emerged when researchers observed that while healthy brain cells synthesize amino acids like serine internally from glucose-derived intermediates, glioblastoma cells downregulate this pathway. Rather than producing their own serine and glycine, the tumor cells rely heavily on scavenging these amino acids from the bloodstream. This metabolic dependency presents a therapeutic vulnerability that the team aimed to exploit.

Building on this knowledge, the investigators designed dietary interventions in mouse models, restricting dietary serine and glycine intake to reduce their availability in the blood. Remarkably, this amino acid restriction enhanced the efficacy of radiation and chemotherapy, resulting in smaller tumors and prolonged survival compared to controls. These findings suggest that manipulating systemic nutrient availability can selectively impair tumor metabolism without harming normal brain function, an innovative concept in cancer therapy.

To quantify and extend these findings, the researchers constructed mathematical models simulating glucose metabolism pathways in the brain. By conceptualizing metabolic fluxes as roads and nutrient pathways as traffic routes, they equated drug targets to roadblocks that could strategically impede cancer’s metabolic highways. Drugs that block key nutrient uptake pathways on heavily trafficked metabolic “freeways” promise far greater therapeutic impact than those targeting less prominent routes used primarily by normal tissues.

This multidisciplinary effort, combining clinical neurosurgery with molecular biology and bioengineering, exemplifies a modern approach to tackling cancer’s complexity. By studying actual human tumors alongside animal models and computational simulations, the team has paved the way for translating metabolic insights into clinical trials. They are currently preparing to evaluate whether specialized diets limiting serine and glycine can replicate the benefits observed in mice for human glioblastoma patients.

The implications of this research extend beyond glioblastoma. Tumor metabolism is increasingly recognized as a hallmark of cancer, and understanding its unique rewiring provides a rich landscape for therapeutic innovation. Targeting metabolic pathways could complement existing treatments, potentially overcoming resistance mechanisms that plague current standard-of-care approaches. This paradigm shift from solely targeting genomic alterations to exploiting metabolic dependencies heralds a promising avenue in precision oncology.

Moreover, this study underscores the importance of conducting metabolic research directly in patients rather than relying solely on in vitro or animal models. The metabolic environment within the human brain is distinct and complex, and only by following glucose metabolism in patients were the researchers able to confirm key pathways operative in human tumors. This patient-centered methodology not only enhances the translational relevance but also opens opportunities for personalized treatment strategies based on metabolic profiling.

Future research will need to elucidate whether other nutrient dependencies exist in glioblastoma and whether combinatorial treatments targeting multiple metabolic pathways yield synergistic effects. Furthermore, clinical trials must carefully balance dietary interventions to avoid malnutrition or adverse effects while maximizing tumor suppression. Nevertheless, the prospect of exploiting metabolic vulnerabilities through diet underscores the ingenuity and adaptability of modern cancer research.

In conclusion, the University of Michigan study reveals a fundamental shift in how glioblastoma cells metabolize glucose, diverting it from energy production toward biosynthesis of key macromolecules necessary for tumor growth and invasion. By leveraging the tumor’s reliance on blood-derived amino acids, particularly serine and glycine, researchers have identified a novel, non-genotoxic strategy to improve treatment response in preclinical models. These findings lay the foundation for new metabolic therapies that could transform clinical outcomes for patients battling this devastating disease.

Subject of Research: Animals

Article Title: Rewiring of cortical glucose metabolism fuels human brain cancer growth

Web References:
https://www.nature.com/articles/s41586-025-09460-7

References:
“Rewiring of cortical glucose metabolism fuels human brain cancer growth,” Nature. DOI: 10.1038/s41586-025-09460-7

Image Credits:
Justine Ross, Michigan Medicine

Keywords:
Health and medicine

Tags: brain tumor treatment strategiescollaboration in cancer researchdietary changes for brain cancerglioblastoma metabolic reprogrammingglioblastoma survival rates and treatmentsglucose utilization in cancer cellsmetabolic pathways in glioblastomanovel therapies for glioblastomaoncology and dietary interventionsresearch on brain cancer therapiestherapeutic diet for malignant tumorstumor metabolism and therapy resistance

Share17Tweet11Share3ShareShareShare2

Related Posts

Decade-Long Clinical Trial Reveals Radiation Matches Surgery in Treating Early-Stage Non-Small Cell Lung Cancer

September 30, 2025

NRG Oncology Trial Reveals Improved Bowel Health Quality of Life in Localized Immediate Risk Prostate Cancer Patients Treated with Stereotactic Body Radiation Therapy

September 29, 2025

Shorter Radiation Enhances Patient Comfort Without Boosting Disease Control in Intermediate-Risk Prostate Cancer

September 29, 2025

First Randomized Trial Shows Proton and Photon Radiation Therapies Equally Preserve Quality of Life in Breast Cancer Patients

September 29, 2025

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    87 shares
    Share 35 Tweet 22
  • Physicists Develop Visible Time Crystal for the First Time

    73 shares
    Share 29 Tweet 18
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    59 shares
    Share 24 Tweet 15
  • Scientists Discover and Synthesize Active Compound in Magic Mushrooms Again

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Assessing Falls Risk Awareness in Seniors and Caregivers

Tunable Microstructures in Bionic Bone Scaffold Design

Hybrid Genetic Algorithm Optimizes Neural Network Image Restoration

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.